Composition
Ranolazine Extended-Release Tablets
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Ranoberg contains Ranolazine, a late sodium current inhibitor that reduces myocardial ischaemia without significantly affecting heart rate or blood pressure.
Indication
Chronic angina in patients who have not achieved adequate response to other anti-anginal agents.
Packaging
10 x 10 Alu-Alu strip pack
Storage
Store below 25°C, protected from light.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.